KLEIN MATTHEW B. (Chief Development Officer) sold 2.6% of their position (10.29K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $705.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0001808968-26-000017
Officer· Chief Development Officer
Since Apr 2020
-10.29K
Net shares
Net seller
$705.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.29K
Price / share
$68.57
Trade value
$705.72K
% of position
2.6%
8/4/2026
394.16K→383.87K
Total
Net shares
−10.29K
Net value
-$705.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2026 | S · Sale | −10.29K | $68.57 | $705.72K | 2.6% | 394.16K | 383.87K |
| Total | −10.29K | -$705.72K | ||||||
Derivative Transactions0
No derivative transactions reported